NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing

Israeli Patent Grant Expands Global Jurisdiction The Israel Patent Office has granted the Company’s Patent, entitled “Production of Extracellular Vesicles from Stem Cells.” This grant aligns with NurExone’s recently announced U.S. Notice of Allowance for the same priority family of applications. “While our clinical and commercial manufacturing of exosomes will

Read More »

Set layout popup